What is Ipsen Price-to-Operating-Cash-Flow?
As of today (2024-04-25), Ipsen's share price is $30.16.
Ipsen's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $2.82. Hence, Ipsen's Price-to-Operating-Cash-Flow Ratio for today is 10.69.
The historical rank and industry rank for Ipsen's Price-to-Operating-Cash-Flow or its related term are showing as below:
IPSEY'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 5.34 Med: 15.08 Max: 32.58
Current: 10.68
During the past 13 years, Ipsen's highest Price-to-Operating-Cash-Flow Ratio was 32.58. The lowest was 5.34. And the median was 15.08.
Ipsen's Cash Flow from Operations per share for the
six
months ended in Dec. 2023 was $1.42.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $2.82.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Ipsen was -11.20% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 4.00% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 10.70% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 19.20% per year.
During the past 13 years, Ipsen's highest 3-Year average Operating Cash Flow per Share Growth Rate was 36.40% per year. The lowest was -17.30% per year. And the median was 15.90% per year.
Ipsen Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Ipsen's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ipsen Price-to-Operating-Cash-Flow Chart
|
Ipsen Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
10.51 |
7.35 |
7.51 |
8.60 |
10.39 |
|
Ipsen Semi-Annual Data
|
|
Jun14 |
Dec14 |
Jun15 |
Dec15 |
Jun16 |
Dec16 |
Jun17 |
Dec17 |
Jun18 |
Dec18 |
Jun19 |
Dec19 |
Jun20 |
Dec20 |
Jun21 |
Dec21 |
Jun22 |
Dec22 |
Jun23 |
Dec23 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
7.51 |
- |
8.60 |
- |
10.39 |
Competitive Comparison of Ipsen's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Ipsen's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ipsen's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ipsen's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Ipsen's Price-to-Operating-Cash-Flow falls into.
Ipsen Price-to-Operating-Cash-Flow Calculation
Ipsen's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 30.16 | / | 2.822 |
| = | 10.69 |
Ipsen's Share Price of today is $30.16.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ipsen's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $2.82.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Ipsen (IPSEY) Business Description
Traded in Other Exchanges
Address
65 Quai Georges Gorse, Billancourt Cedex, Boulogne, FRA, 92100
Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders. Over the past nearly 100 years, Ipsen has shifted its focus to specialty care, which comprises the vast majority of its total revenue. In February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 25 drugs in 115 countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IPSEY has been successfully added to your